GGrantIndex
← Search

CLINICAL TRIAL: A 12-WEEK STUDY TO EVALUATE THE SAFETY OF AT1001 IN PATIENTS WIT

$4,386M01FY2008RRNIH

Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center, Torrance CA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →